General practitioners’ approaches to prostate-specific antigen testing in the north-east of the Netherlands

PSA-Screening und molekulare Marker

(2019) J. Lakes et al.   UROLOGE

General practitioners’ attitudes towards early diagnosis of dementia: a cross-sectional survey

(2019) Stéphanie Giezendanner et al.   BMC Family Practice

Early detection of prostate cancer using prostate-specific antigen testing: an empirical evaluation among general practitioners and urologists

(2019) Sanny Kappen et al.   Cancer Management and Research

Primary Care Physicians Beliefs about Prostate-Specific Antigen Evidence Uncertainty, Screening Efficacy, and Test Use

(2018) Louie E. Ross et al.   JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION

General Practitioners and Bariatric Surgery in France: Are They Ready to Face the Challenge?

(2018) Francesco Martini et al.   OBESITY SURGERY

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis

(2018) Dragan Ilic et al.   BMJ-British Medical Journal

The readiness of German GPs to recommend and conduct cancer screening is associated with patient–physician gender concordance. Results of a survey

(2016) Jennifer Engler et al.   European Journal of General Practice

Doctors' perspectives on PSA testing illuminate established differences in prostate cancer screening rates between Australia and the UK: a qualitative study

(2016) Kristen Pickles et al.   BMJ Open

Prostate cancer screening in Primary Health Care: the current state of affairs

(2015) Weranja KB Ranasinghe et al.   SpringerPlus

Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: An ecological study

(2014) Peter Hjertholm et al.   INTERNATIONAL JOURNAL OF CANCER

Impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC) on prostate-specific antigen (PSA) testing by Dutch general practitioners

(2013) Saskia Van der Meer et al.   BJU INTERNATIONAL

Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review

(2012) Saskia Van der Meer et al.   BMC Family Practice

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

(2012) G. L. Andriole et al.   JNCI-Journal of the National Cancer Institute

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prostate cancer incidence trends in Spain before and during the prostate-specific antigen era: impact on mortality

(2010) N. Larranaga et al.   ANNALS OF ONCOLOGY

Prostate cancer incidence and mortality trends in 37 European countries: An overview

(2010) F. Bray et al.   EUROPEAN JOURNAL OF CANCER

Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners

(2009) Frances J Drummond et al.   BMC Family Practice

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE